Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mirapexin 0.088mg tablets
0409010W0BBACAC
|
Mirapexin | Pramipexole | Central Nervous System | 673 |
|
Mirapexin 0.18mg tablets
0409010W0BBABAB
|
Mirapexin | Pramipexole | Central Nervous System | 288 |
|
Mirapexin 1.05mg modified-release tablets
0409010W0BBAGAG
|
Mirapexin | Pramipexole | Central Nervous System | 228 |
|
Mirapexin 0.52mg modified-release tablets
0409010W0BBAFAF
|
Mirapexin | Pramipexole | Central Nervous System | 187 |
|
Mirapexin 2.1mg modified-release tablets
0409010W0BBAHAH
|
Mirapexin | Pramipexole | Central Nervous System | 173 |
|
Mirapexin 1.57mg modified-release tablets
0409010W0BBAJAJ
|
Mirapexin | Pramipexole | Central Nervous System | 170 |
|
Mirapexin 0.26mg modified-release tablets
0409010W0BBAEAE
|
Mirapexin | Pramipexole | Central Nervous System | 158 |
|
Mirapexin 3.15mg modified-release tablets
0409010W0BBAIAI
|
Mirapexin | Pramipexole | Central Nervous System | 134 |
|
Mirapexin 0.35mg tablets
0409010W0BBADAD
|
Mirapexin | Pramipexole | Central Nervous System | 124 |
|
Mirapexin 0.7mg tablets
0409010W0BBAAAA
|
Mirapexin | Pramipexole | Central Nervous System | 93 |
|
Mirapexin 2.62mg modified-release tablets
0409010W0BBAKAK
|
Mirapexin | Pramipexole | Central Nervous System | 79 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.